These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35268597)

  • 1. Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake.
    Liu L; Yang S; Chen F; Cheng KW
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide-Zein Composite Nanoparticles for Enhancing Cellular Uptake and Oral Bioavailability of Curcumin: Characterization, Anti-colorectal Cancer Effect, and Pharmacokinetics.
    Liu L; Yang S; Chen F; Cheng KW
    Front Nutr; 2022; 9():846282. PubMed ID: 35308263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
    Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
    Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
    Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
    Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate conjugated hyaluronic acid coated alginate nanogels encapsulated oxaliplatin enhance antitumor and apoptosis efficacy on colorectal cancer cells (HT29 cell line).
    Shad PM; Karizi SZ; Javan RS; Mirzaie A; Noorbazargan H; Akbarzadeh I; Rezaie H
    Toxicol In Vitro; 2020 Jun; 65():104756. PubMed ID: 31884114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
    Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
    Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
    Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
    Wei X; Senanayake TH; Bohling A; Vinogradov SV
    Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of curcumin by functional solid lipid nanoparticles with promoting endosomal escape and liver targeting properties.
    Zhang M; Liang J; Liang Y; Li X; Wu W
    Colloids Surf B Biointerfaces; 2024 Dec; 244():114177. PubMed ID: 39217729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage.
    Hu JB; Li SJ; Kang XQ; Qi J; Wu JH; Wang XJ; Xu XL; Ying XY; Jiang SP; You J; Du YZ
    Carbohydr Polym; 2018 Aug; 193():268-280. PubMed ID: 29773381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Attenuates Oxaliplatin-Induced Liver Injury and Oxidative Stress by Activating the Nrf2 Pathway.
    Lu Y; Wu S; Xiang B; Li L; Lin Y
    Drug Des Devel Ther; 2020; 14():73-85. PubMed ID: 32021093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
    Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
    Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
    Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.